| Pharmaceutical active ingredients: |
| Bisoprolol FumarateHydrochlorothiazide |
| Available forms, composition and doses of Orloc Comp: |
| N / A |
| Orloc Comp medical category: |
| Human:Beta-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07BB07 - Bisoprolol and thiazides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Orion Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Emcoretic | Bisoprolol Fumarate; Hydrochlorothiazide | Merck |
| Fondril HCT | Bisoprolol Fumarate; Hydrochlorothiazide | Procter & Gamble |
| Maxsoten | Bisoprolol Fumarate; Hydrochlorothiazide | Wyeth |
| Monozide | Bisoprolol Fumarate; Hydrochlorothiazide | Wyeth |
| Nanalan Plus | Bisoprolol Fumarate; Hydrochlorothiazide | Merck |
| Qualiz | Bisoprolol Fumarate; Hydrochlorothiazide | Medreich |
| Rivacor Plus | Bisoprolol Fumarate; Hydrochlorothiazide | Lannacher Heilmittel |
| Wytens | Bisoprolol Fumarate; Hydrochlorothiazide | Wyeth; Meda |
| Zabesta-XLO | Bisoprolol Fumarate; Hydrochlorothiazide | USV, India |
| Ziac | Bisoprolol Fumarate; Hydrochlorothiazide | Merck; Barr Laboratories; Duramed Pharmaceuticals; Serono; Zuellig Pharma |